For this purpose, a lentiviral vector containing short-hairpin RNA targeting hCtr1 (Lenti-hCtr1-shRNA) was designed to achieve RNA interference-mediated reduction of hCtr1 expression in prostate cancer cells. Here, SLC31A1 is linked to prostate carcinoma.